Search research articles
Contact Us
Filters
Showing results (1-10 of 55) with videos related to
Page
of 6
Sort By:
Minnesota Medicine
|
July 18, 2014
A closer view. The realities of practicing medicine in Tanzania
Jonathan D Alpern
Clinical Pharmacology and Therapeutics
|
April 21, 2020
Off-Label Therapies for COVID-19-Are We All In This Together?
Jonathan D Alpern, Elie Gertner
Postgraduate Medical Journal
|
March 26, 2017
Minocycline-induced skin hyperpigmentation
Jonathan D Alpern, Anjum Kaka
The New England Journal of Medicine
|
January 9, 2020
Cutaneous Leishmaniasis
Alexia P Knapp, Jonathan D Alpern
Frontiers in Sociology
|
April 19, 2021
Antiparasitic Drugs in the United States-Two Roads to High Prices
Arman A Shahriar, Jonathan D Alpern
Journal of General Internal Medicine
|
March 24, 2026
Relevant Industry Payments to 2023-2024 Voting Members of the Advisory Committee on Immunization Practices
Jonathan D Alpern, Aaron S Kesselheim
Journal of Managed Care & Specialty Pharmacy
|
October 1, 2021
Drug-dispensing limits within Medicaid during the COVID-19 pandemic
Jonathan D Alpern, Nathan Chomilo, Malini DeSilva
Open Forum Infectious Diseases
|
June 18, 2021
The Erosion of Public Trust and SARS-CoV-2 Vaccines- More Action Is Needed
Ari Nahum, Dimitri M Drekonja, Jonathan D Alpern
Case Reports in Infectious Diseases
|
March 11, 2017
Prosthetic Joint Infection due to <i>Mycobacterium avium-intracellulare</i> in a Patient with Rheumatoid Arthritis: A Case Report and Review of the Literature
Nicholas E Ingraham, Brenton Schneider, Jonathan D Alpern
The New England Journal of Medicine
|
September 1, 2016
Access to Essential Medicines in the United States
Jonathan D Alpern, John Song, William M Stauffer
Page
of 6
Search research articles
Search
Showing results (1-10 of 55) with videos related to
Sort By:
Page
of 6
Minnesota Medicine
|
July 18, 2014
A closer view. The realities of practicing medicine in Tanzania
Jonathan D Alpern
Clinical Pharmacology and Therapeutics
|
April 21, 2020
Off-Label Therapies for COVID-19-Are We All In This Together?
Jonathan D Alpern, Elie Gertner
Postgraduate Medical Journal
|
March 26, 2017
Minocycline-induced skin hyperpigmentation
Jonathan D Alpern, Anjum Kaka
The New England Journal of Medicine
|
January 9, 2020
Cutaneous Leishmaniasis
Alexia P Knapp, Jonathan D Alpern
Frontiers in Sociology
|
April 19, 2021
Antiparasitic Drugs in the United States-Two Roads to High Prices
Arman A Shahriar, Jonathan D Alpern
Journal of General Internal Medicine
|
March 24, 2026
Relevant Industry Payments to 2023-2024 Voting Members of the Advisory Committee on Immunization Practices
Jonathan D Alpern, Aaron S Kesselheim
Journal of Managed Care & Specialty Pharmacy
|
October 1, 2021
Drug-dispensing limits within Medicaid during the COVID-19 pandemic
Jonathan D Alpern, Nathan Chomilo, Malini DeSilva
Open Forum Infectious Diseases
|
June 18, 2021
The Erosion of Public Trust and SARS-CoV-2 Vaccines- More Action Is Needed
Ari Nahum, Dimitri M Drekonja, Jonathan D Alpern
Case Reports in Infectious Diseases
|
March 11, 2017
Prosthetic Joint Infection due to <i>Mycobacterium avium-intracellulare</i> in a Patient with Rheumatoid Arthritis: A Case Report and Review of the Literature
Nicholas E Ingraham, Brenton Schneider, Jonathan D Alpern
The New England Journal of Medicine
|
September 1, 2016
Access to Essential Medicines in the United States
Jonathan D Alpern, John Song, William M Stauffer
Page
of 6